stockrowWaters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
- Revenue
- +120.9%
- EPS
- −67.0%
- Free cash flow
- −66.7%
- Total debt
- +308.2%
Quarter to September 2026, against a year earlier
Follow WAT
Alert me
Waters Corporation (WAT) Book value per share
Waters Corporation's book value per share at the end of fiscal 2025 was 43.0×, up 39.7% from 30.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 156×. Over the past ten years it has ranged from −3.2× (fiscal 2019) to 43.0× (fiscal 2025) — the current reading is the highest in ten years. Waters Corporation ranks 1st of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 43.0× | 39.66% |
| FY2024 | 30.8× | 58.27% |
| FY2023 | 19.5× | 131.53% |
| FY2022 | 8.4× | 40.89% |
| FY2021 | 6.0× | 59.66% |
| FY2020 | 3.7× | — |
| FY2019 | −3.2× | — |
| FY2018 | 20.4× | (27.29%) |
| FY2017 | 28.0× | (1.75%) |
| FY2016 | 28.5× | 13.95% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 156× | 0.58% |
| Jun 2026 | 155× | (16.89%) |
| Mar 2026 | 186× | 332.43% |
| Dec 2025 | 43.1× | 9.96% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| WAT Waters Corporation | 156× |
| LH Labcorp Holdings Inc. compare | 109× |
| DGX Quest Diagnostics Incorporated compare | 72.3× |
| IQV IQVIA Holdings Inc. compare | 41.2× |
| A Agilent Technologies, Inc. compare | 26.1× |
| IDXX IDEXX Laboratories, Inc. compare | 23.7× |
| ILMN Illumina, Inc. compare | 20.8× |
| NTRA Natera, Inc. compare | 13.0× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on WAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement